Dialysis Market Synopsis

Dialysis Market Size Was Valued at USD 95.22 Billion in 2023 and is Projected to Reach USD 193.54 Billion by 2032, Growing at a CAGR of 8.2% From 2023-2032.

Hemodialysis is a therapy utilized by patients suffering from chronic kidney disease and is a technological substitute for damaged kidneys. It entails filtration of waste products and unnecessary fluids out of the blood – roles that healthy kidneys are meant to play. Dialysis is required in cases where the kidneys are not able to purify blood sufficiently due to either CKD or AKI. There are two primary types of dialysis: End-stage renal disease treatment: hemodialysis, which relies on External Arm Circuits and peritoneal dialysis, which uses abdominal cavity to clean the blood.

• Patients who require renal replacement therapy can undergo it through a procedure known as dialysis, with the most familiar type being hemodialysis. It entails using a machine called dialyzer or artificial kidney to filter the patient’s blood which is then circulated outside the body. The dialyzer removes waste products and fluids and interrupts pathogens from entering the patient’s body and serves the cleaned blood back. This process usually entails manipulation of the patients blood through an artificial site created through surgery commonly referred to as fistula, graft or a catheter. Hemodialysis can be conducted in a hospital, or at a dialysis clinic; however, the process can also be carried out at the patient’s home provided the necessary instruments and education are available. It involves requiring treatment about three times per week, and each session may last approximately four hours on average.
• The other form, peritoneal dialysis, employs the lining of the abdomen called the peritoneum as a naturally formed membrane that is also used in filtering the wastes and the excess fluid in the body. The dialysate is a special kind of fluid that is contained in the peritoneal cavity and is inserted through a catheter. As shown in figure one, the waste products and excess fluids from the blood pass into the dialysate which is thereafter disposed off while fresh dialysate is circulated through the body. CAPD can be carried out several times a day while APD is achieved through a machine during the night. Compared with HD, peritoneal dialysis is less rigid, and patients can do it at home, hence given more freedom in the time used on the program.

Dialysis Market Trend Analysis

Shift Towards Home Dialysis

• Growing popularity of home dialysis can be considered as one of the trends in dialysis market that can be influenced by the drive for development of technologies, patients’ choice and the changes in health care policies. PD as well as HHD, which are considered home dialysis treatments, have been proven to be more flexible and convenient than standard in-center dialysis. Recent advancements in dialysis technology that have made home dialysis possible and safe more than old generations equipment that demands technical skill. These technologies help patients improve adherence to prescribed treatment plans and make their lives richer and more fulfilling by allowing them to carry out care plans without having to frequently check into a hospital.
• There is still flexibility provided by the patients, who are now the consumers of the healthcare delivery system. Patients prefer home dialysis because it enables them to be in control of the process, and set own limits. In fact, one of the benefits of PD is that patients are able to literally save time than when having to travel and wait for their dialysis session in a centre. Furthermore, since home dialysis is less risky than going to the hospital for dialysis, overall health may improve in areas like cardiovascular disease or infection prevention.
• Flexible appointment options are called by names as they are valued according to personal preferences and convenience when it comes to appointment schedules with healthcare facilities like that of dialysis since this substantially enhance the patients’ level of compliance onto treatment regimen proposed with a consequential boost on wellbeing.
• Many other also add health care policies and re-imbursement models for playing crucial role in triggering the home dialysis. Currently, in several countries, governments and insurance companies have employed incentives and/or better reimbursement schedules for the promotion of home dialysis. This is partly so because home dialysis is likely to prove to be less costly to the healthcare fund as it does not entail a lot of infrastructure and the personnel that could be provided for in a hospital setting.
• In addition, we have reported that efforts to increase the number of patients treated with home dialysis are also part of a larger trend toward patient-centered care, which is based on the principle that patients are better served with treatments that are consistent with their preferences and goals. For this reason, the demand for home dialysis technologies and support services is a freshly procured market segment of the dialysis market, and it should once again continue to experience sustained growth in the future.

Advancements in genomics and personalized medicine

• Utilizing the advancements in genomics and personalized medicine has potential in strategic growth deals for the dialysis market as the trends in this domain target more effective treatments for patients suffering from kidney diseases. It says that Genomics lead to the identification of genes involved in the processes of kidney diseases, thereby, creating a platform for early detection, and treatment. One potential benefit of precision medicine that adapts treatment according to the molecular characteristics of an individual comprises of increasing client results in that the treatments being administered have better efficacy and reduced adverse effects. ‘”This approach can result in new dialysis solutions hence, advancements in dialysis equipments like machines, or the coming up with pharmacogenomic routines that enhance the utilization of drugs in dialysis individuals. ”
• Genomic information incorporated into the patient’s clinical workflow may reveal new diagnostic markers that could identify the likelihood and pace of the disease’s progression, as well as the effectiveness of the treatment process. By providing a deeper understanding of the particular sickness, risk, and treatment, the dialysis market means that the providers can utilize data stratification to classify patients appropriately and adjust dialysis regimens consequently.
• For example, people possessing certain genes can opt for clarified or enhanced dialysis cycles while others may require that the sessions be fewer or less rigorous. This phenomenon can help to better plan resource distribution and the effectiveness of the dialysis programs, and thereby exclude healthcare expenditure and the quality of the patients’ lives from being enhanced.
• The key opportunities aera derived from the emergence of genomics and personalized medicine, may in turn foster new advances in the dialysis related technologies and interventions. For instance, patients might be prescribed portable or home use dialysis equipment that is personalized to their DNA results, as such devices will eventually be as widespread as home dialysis devices. Biotechnology may also expand new drugs for traditional genetic pathology of kidney diseases and hence decrease the application for dialysis at all. And by adopting these technologies the dialysis market may not only enhance patient’s experience and clinical benefits, but also open new economic niches and develop the vision of the primary kidney disease management throughout the world.

Dialysis Market Segment Analysis:

Dialysis Market Segmented on the basis of Treatment Type, Dialysis Type, and End User.

By Type, Products segment is expected to dominate the market during the forecast period

• The dialysis market can be categorized according to product and services, however the product segment of the dialysis business is the biggest compared to the services segment. This occupancy is attributed by the fact that dialysis products are basic and temporary commodities used in delivering essential services comprising haemodialysis machines, peritoneal dialysis machines, dialyzers, catheters, and concentrates. These products are necessary in the provision of dialysis solutions so as to help patients who have to go through dialysis as a routine activity either at dialysis centers or at home. ESRD and CKD have also been on the rise in the recent past, and, therefore, such products are popular among patients who are ailing from these diseases and create a large portion of market revenue. Advancements in dialsysis equipment, namely in the actual equipment that is used for the treatment, have also ensured consistant support towards the products segment, contributing towards the segment’s dominance.
• Additionally, products segment has a steady demand due to new sets of consumables dor dialysis namely dialyzers and concentrates which are used in each session. Due to the repetitive use of these consumables, it would be possible to realize semi-cyclic or cyclic income for the producers. Furthermore, growth in home dialysis due to flexibility in dialysis timing as compared to the more rigid schedule of in-center dialysis has contributed to the need for portable dialysis equipment and associated products. This trend is set to carry on, with more identifiable patients and health care practitioners acknowledging the advantages of home use dialysis hence strengthening the leading position of product segment in the market.
• By contrast, the services segment remains significant but does not present a market share as great as the products segment. It comprehends the Dialysis Treatment that is offered as in-center, home training and other forms of supportive care. The aspect contributing towards the growth of the segment being the increase in the number of dialysis centres and the progression in the health care systems across the world. However, the initial and recurrent capital costs of establishing and operating dialysis centers, the steady capital needs, and the ongoing operating costs present some key problems in the rapid expansion of the services segment. Hence, they retained the leading position in the market even with the further growth of the demand for dialysis services, the products segment is still ahead of time, as it plays a crucial role in the dialysis process and has a stable demand thanks to high consumption rates of consumables.

By Cancer Type, Exocrine Dialysis segment held the largest share in 2023

• The dialysis market is broadly classified into two major categories: products and services; however, the products segment holds the largest share in the total dialysis market currently. The following is an analysis of the products: Hemodialysis Machines, Peritoneal Dialysis Machines, Dialyzers, Catheters, Concentrates; The majority of these products are essential and may have to be replaced repeatedly hence the high demand. These products are tools vital for the proper conduct of dialysis interventions that may be administered at dialysis stations or at home. The factors such as rise in the incidence of end-stage renal disease (ESRD) and chronic kidney disease (CKD) have influenced the growth of the product developement and thus, augmenting the overal market revenue. Technological developments in dialysis equipment are also cited to have contributed to investment in improving the efficiency of the systems, which is a factor that has reinforced the solidification of the products segment.
• In addition, there is significant growth also coming from the consumables or the products segment including dialyzer and concentrate, where patients need it daily for a dialysis procedure. Due to ongoing consumption, the constant replacement of these consumables guarantees consistent earnings for producers. Also, following the advancements in technology, growth in home dialysis has been experienced due to patients’ flexibility it offers; thus boosting the portable dialysis machines and other associated products. This trend is anticipated to persist given the increasing consciousness about home-based dialysis among the patients and the healthcare providers strengthening the predominance of the products segment in the market.
• In contrast to the products segment of the industry, the services segment, while significant, does not command the same level of market share. Services include haemodialysis delivered both at the centre and patients homes, home dialysis training, and other support services. The segment across the services is driven by an increase in dental facilities, such as dialysis centers and global healthcare facilities. Nevertheless, the set up costs for the centres, the fixed capital and recurring costs associated with dialysis presents itself as a constraint to growth of the services segment. Therefore, the products segment remains dominant in the market, owing to the higher demand for dialysis services, as well as the inherent necessity of using dialsates in the procedure and consumption of consumables.

Dialysis Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period

• The high market penetration of dialysis in North America can be explained by the increased incidence of CKD, availability of a highly technical medical setting in this region, and increased companies’ focus on research and development. There has been an observed increase of CKD prevalence in the region and more especially in the United States and lifestyle diseases such as diabetes and high-blood pressure which are known to be precipitating factors to kidney diseases. Hence this high prevalence of CKD results in a large patient population progressing to stage 5 CKD that will require dialysis and will contribute to the growth of the market.
• The third factor that can be postulated is the level of development of the HC in the North American countries. The region is well endowed with health facilities highly equipped with advanced systems in offering dialysis services. This encompasses many specialized dialysis processes, various enhanced care procedures and, most importantly, a highly qualified team of nephrologists and health care personnel charged with the responsibility of handling kidney ailments. Furthermore, it is supported by highly potential and developed dialysis service providers and medical device industries in North America, which guarantees mass availability of high-tech dialysis apparatuses and treatments, contributing to the regional market’s durability.
• In conclusion, emphasis on R & D serve as a strategic factor in ensuring North America dominates the market in dialysis. Techniques of dialysis, dialysis equipment and practices used to care for dialysis patients are constantly being developed in order to be more effective. Currently, government agencies private firms and academic institutions work hand in hand in conducting research activities in the development of better dialysis techniques and process. This commitment to ongoing innovation not only enhances dialysis efficiency thus leading to better patient prognosis but also reinforces North America’s position within the international dialysis market.

Active Key Players in the Dialysis Market

• Asahi Kasei Corporation (Japan)
• AWAK Technologies (Singapore)
• B. Braun Melsungen AG (Germany)
• Baxter International Inc. (United States)
• Cantel Medical Corporation (United States)
• DaVita Inc. (United States)
• Dialife SA (Switzerland)
• Fresenius Medical Care (Germany)
• Isopure Corp (United States)
• JMS Co. Ltd. (Japan)
• Medica SpA (Italy)
• Medtronic Plc (Ireland)
• Nikkiso Co., Ltd. (Japan)
• Nipro Corporation (Japan)
• NxStage Medical, Inc. (United States)
• Outset Medical, Inc. (United States)
• Quanta Dialysis Technologies Ltd. (United Kingdom)
• Rockwell Medical, Inc. (United States)
• Terumo Corporation (Japan)
• Toray Medical Co., Ltd. (Japan), Other Major Players.

Key Industry Developments in the Dialysis Market:

• In October 2023, Northeast Georgia Health Ventures (NGHV) and Dialyze Direct has formed a partnership that will enhance smoother and efficient patient care. HHA as home dialysis services to skilled nursing facilities (SNFs) in Georgia.
• In August 2023, Fresenius Medical Care, joined forces with Sarah Bush Lincoln, a regional health system in Illinois to the provision of dialysis services to its constituent rural patients. Out of this collaboration, it was agreed that dialysis services would be conducted within the facility.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Dialysis Market by Type
 4.1 Dialysis Market Snapshot and Growth Engine
 4.2 Dialysis Market Overview
 4.3 Products
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Products: Geographic Segmentation Analysis
 4.4 Services
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Services: Geographic Segmentation Analysis

Chapter 5: Dialysis Market by Dialysis Type
 5.1 Dialysis Market Snapshot and Growth Engine
 5.2 Dialysis Market Overview
 5.3 Hemodialysis
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Hemodialysis: Geographic Segmentation Analysis
 5.4 Peritoneal Dialysis
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Peritoneal Dialysis: Geographic Segmentation Analysis

Chapter 6: Dialysis Market by End-User
 6.1 Dialysis Market Snapshot and Growth Engine
 6.2 Dialysis Market Overview
 6.3 Dialysis Centers & Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Dialysis Centers & Hospitals: Geographic Segmentation Analysis
 6.4 Home Care
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Home Care: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Dialysis Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 ASAHI KASEI CORPORATION (JAPAN)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 AWAK TECHNOLOGIES (SINGAPORE)
 7.4 B. BRAUN MELSUNGEN AG (GERMANY)
 7.5 BAXTER INTERNATIONAL INC (UNITED STATES)
 7.6 CANTEL MEDICAL CORPORATION (UNITED STATES)
 7.7 DAVITA INC (UNITED STATES)
 7.8 DIALIFE SA (SWITZERLAND)
 7.9 FRESENIUS MEDICAL CARE (GERMANY)
 7.10 ISOPURE CORP (UNITED STATES)
 7.11 JMS CO LTD (JAPAN)
 7.12 MEDICA SPA (ITALY)
 7.13 MEDTRONIC PLC (IRELAND)
 7.14 NIKKISO CO LTD (JAPAN)
 7.15 NIPRO CORPORATION (JAPAN)
 7.16 NXSTAGE MEDICAL INC (UNITED STATES)
 7.17 OUTSET MEDICAL INC (UNITED STATES)
 7.18 QUANTA DIALYSIS TECHNOLOGIES LTD (UNITED KINGDOM)
 7.19 ROCKWELL MEDICAL INC (UNITED STATES)
 7.20 TERUMO CORPORATION (JAPAN)
 7.21 TORAY MEDICAL CO LTD (JAPAN)

Chapter 8: Global Dialysis Market By Region
 8.1 Overview
 8.2. North America Dialysis Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
   8.2.4.1 Products
   8.2.4.2 Services
  8.2.5 Historic and Forecasted Market Size By Dialysis Type
   8.2.5.1 Hemodialysis
   8.2.5.2 Peritoneal Dialysis
  8.2.6 Historic and Forecasted Market Size By End-User
   8.2.6.1 Dialysis Centers & Hospitals
   8.2.6.2 Home Care
  8.2.7 Historic and Forecast Market Size by Country
   8.2.7.1 US
   8.2.7.2 Canada
   8.2.7.3 Mexico
 8.3. Eastern Europe Dialysis Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
   8.3.4.1 Products
   8.3.4.2 Services
  8.3.5 Historic and Forecasted Market Size By Dialysis Type
   8.3.5.1 Hemodialysis
   8.3.5.2 Peritoneal Dialysis
  8.3.6 Historic and Forecasted Market Size By End-User
   8.3.6.1 Dialysis Centers & Hospitals
   8.3.6.2 Home Care
  8.3.7 Historic and Forecast Market Size by Country
   8.3.7.1 Bulgaria
   8.3.7.2 The Czech Republic
   8.3.7.3 Hungary
   8.3.7.4 Poland
   8.3.7.5 Romania
   8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Dialysis Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
   8.4.4.1 Products
   8.4.4.2 Services
  8.4.5 Historic and Forecasted Market Size By Dialysis Type
   8.4.5.1 Hemodialysis
   8.4.5.2 Peritoneal Dialysis
  8.4.6 Historic and Forecasted Market Size By End-User
   8.4.6.1 Dialysis Centers & Hospitals
   8.4.6.2 Home Care
  8.4.7 Historic and Forecast Market Size by Country
   8.4.7.1 Germany
   8.4.7.2 UK
   8.4.7.3 France
   8.4.7.4 Netherlands
   8.4.7.5 Italy
   8.4.7.6 Russia
   8.4.7.7 Spain
   8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Dialysis Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
   8.5.4.1 Products
   8.5.4.2 Services
  8.5.5 Historic and Forecasted Market Size By Dialysis Type
   8.5.5.1 Hemodialysis
   8.5.5.2 Peritoneal Dialysis
  8.5.6 Historic and Forecasted Market Size By End-User
   8.5.6.1 Dialysis Centers & Hospitals
   8.5.6.2 Home Care
  8.5.7 Historic and Forecast Market Size by Country
   8.5.7.1 China
   8.5.7.2 India
   8.5.7.3 Japan
   8.5.7.4 South Korea
   8.5.7.5 Malaysia
   8.5.7.6 Thailand
   8.5.7.7 Vietnam
   8.5.7.8 The Philippines
   8.5.7.9 Australia
   8.5.7.10 New Zealand
   8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Dialysis Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
   8.6.4.1 Products
   8.6.4.2 Services
  8.6.5 Historic and Forecasted Market Size By Dialysis Type
   8.6.5.1 Hemodialysis
   8.6.5.2 Peritoneal Dialysis
  8.6.6 Historic and Forecasted Market Size By End-User
   8.6.6.1 Dialysis Centers & Hospitals
   8.6.6.2 Home Care
  8.6.7 Historic and Forecast Market Size by Country
   8.6.7.1 Turkey
   8.6.7.2 Bahrain
   8.6.7.3 Kuwait
   8.6.7.4 Saudi Arabia
   8.6.7.5 Qatar
   8.6.7.6 UAE
   8.6.7.7 Israel
   8.6.7.8 South Africa
 8.7. South America Dialysis Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
   8.7.4.1 Products
   8.7.4.2 Services
  8.7.5 Historic and Forecasted Market Size By Dialysis Type
   8.7.5.1 Hemodialysis
   8.7.5.2 Peritoneal Dialysis
  8.7.6 Historic and Forecasted Market Size By End-User
   8.7.6.1 Dialysis Centers & Hospitals
   8.7.6.2 Home Care
  8.7.7 Historic and Forecast Market Size by Country
   8.7.7.1 Brazil
   8.7.7.2 Argentina
   8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research